Despite tough market conditions and a stock pullback, DocuSign (DOCU) remains on the radar of some bullish analysts, anchored by its $124 price target set by Citizens analyst Patrick Walravens, implying a 171.2% upside from recent stock prices.
Analysts at Citizens, which maintains an “Outperform” rating on DOCU, view DocuSign as a compelling capital appreciation opportunity, citing its dominant e-signature franchise and strong total addressable market as compelling long-term growth drivers.
This bullish valuation underscores a dramatic potential turnaround for a stock that has been under pressure amid slower e-signature turnover, suggesting, among some strategists, that DocuSign could generate substantial appreciation through 2026.
DocuSign is a software company based in San Francisco, California, providing cloud-based e-signature and digital agreement management solutions to businesses and organizations around the world. The company’s platform allows users to securely prepare, sign, act on and manage agreements across multiple devices, and has expanded to broader agreement automation and intelligent contract lifecycle offerings. DocuSign’s market capitalization is around $9.2 billion.
DocuSign’s stock price has seen significant weakness over the past year and into 2026, reflecting both the company’s specific execution challenges and broader software stock sell-offs. In the last 52 weeks, DOCU has fallen sharply by 52% from its highs of around $94.67 reached in June 2025. The stock is down 44.25% over the past year.
Year-to-date (YTD), DocuSign stock has continued to struggle, down around 33.76% year to date, underperforming the broader major indices and reinforcing the bearish trend. Additionally, the stock fell to its 52-week low of $40.16 on February 25.
DocuSign stock is falling in 2026 largely due to weakening investor confidence, widespread pressure from the software sector as investors abandon growth names, and negative actions by analysts. Additionally, skepticism around the company’s ability to quickly revive growth, particularly in its transition to the Intelligent Agreement Management (IAM) platform, relatively conservative guidance for billing and revenue weighed on sentiment.
www.barchart.com
The stock currently trades at 2.94 times sales, which is a discount to the sector median.
DocuSign’s fiscal third quarter 2026 results, released on December 4, 2025 for the period ending October 31, showed a continuation of modest growth with several key metrics improving year over year (YOY), but also highlighted why investors are cautious about the company’s growth trajectory.
Total revenue was $818.4 million, an increase of 8% compared to the previous year, while subscription revenue, the core of DocuSign’s SaaS business, grew 9% to $801 million, and billings increased 10% to $829.5 million.
Non-GAAP gross margin fell slightly to 81.8% and profitability improved significantly with non-GAAP EPS of $1.01, up from $0.90 in the prior-year quarter and above the consensus estimate.
The company also reported stronger cash flow, with net cash from operating activities of approximately $290.3 million and free cash flow of $262.9 million, both higher than the year-ago period.
Despite these positives, professional services revenue declined 14% and margin compression in certain areas underscored a mixed execution dynamic.
For the quarter ending January 31, 2026, DocuSign achieved between $825 million and $829 million in total revenue (up 7% year over year), between $808 million and $812 million in subscription revenue (also up 7% year over year), and between $992 million and $1,002 billion in billings (up about 8% year over year), while reiterating expectations for the full fiscal year. 2026 of approximately $3,208 billion to $3,212 billion in revenue and $3,379 billion to $3,389 billion in revenue.
This combination of strong revenue expansion and lackluster forecasts tempered enthusiasm as the market looked for evidence of a stronger acceleration in growth beyond mid-single-digit increases.
Analysts forecast EPS of $1.43 for fiscal 2026, up 22.2% year-over-year, followed by a further 12.6% rise to $1.61 in 2027.
While companies like Citizens remain constructive on DocuSign, some analysts have become more cautious in recent weeks.
Notably, Jefferies downgraded the stock from “Buy” to “Hold,” and analyst Brent Thill cut the price target from $105 to $45, a sharp 57.1% reduction.
Additionally, on February 18, BTIG analyst Allan Verkhovski reiterated a “Buy” rating but lowered his price target from $88 to $70, a 20.5% downward revision.
Overall, DOCU has a consensus rating of “Moderate Buy.” Of the 20 analysts covering the stock, five recommend a “Strong Buy” and the remaining 15 analysts give it a “Hold” rating.
The average price target of $79.19 suggests 73.2% upside potential from current prices.
www.barchart.com
On the date of publication, Subhasree Kar had no positions (either directly or indirectly) in any of the securities mentioned in this article. All information and data in this article are for informational purposes only. This article was originally published on Barchart.com
